RefleXion Showcases Breakthrough SCINTIX Biology-Guided Radiotherapy and Highlights New Research at ASTRO 2023 Meeting
RefleXion® Medical , a therapeutic oncology company, today announced the company will showcase the RefleXion® X1 with SCINTIX™ biology-guided radiotherapy at the American Society for Radiation Oncology ( ASTRO ) Annual Meeting, Oct. 1-4, 2023 in San Diego (booth #2831).
- RefleXion® Medical , a therapeutic oncology company, today announced the company will showcase the RefleXion® X1 with SCINTIX™ biology-guided radiotherapy at the American Society for Radiation Oncology ( ASTRO ) Annual Meeting, Oct. 1-4, 2023 in San Diego (booth #2831).
- “Highlights from these presentations explore critical aspects of X1 performance in dosimetric accuracy, workflow, FDG uptake, and exquisite kVCT image quality.
- The following oral and panel presentations highlight some of the new research being presented at ASTRO 2023.
- The RefleXion booth will also feature a multi-target SCINTIX technology interactive demonstration and SCINTIX treatment planning demonstrations.